1) E Fund (HK) HKEX Tech 100 Index Fund (the “Sub-Fund”) is a sub-fund of the E Fund Investment Fund Series OFC, which is a public umbrella open-ended fund company established under Hong Kong law. The Sub-Fund is a feeder fund and a passively managed index tracking fund authorised under Chapter 7 and Chapter 8.6 of the Code on Unit Trusts and Mutual Funds (the “Code”) issued by the Securities and Futures Commission (the “SFC”), investing at least 90% of its Net Asset Value (“NAV”) in E Fund (HK) HKEX Tech 100 Index ETF (the “Master ETF”), which is listed on The Stock Exchange of Hong Kong Limited (the “SEHK”) and tracking the HKEX Tech 100 Net Total Return Index (the “Index”).
2) Investment involves risks. The Sub-Fund is subject to a) Investment risk, b) Risks of investing in the Master ETF, c) Currency risks, d) RMB currency risk and RMB denominated classes risk, e) Termination risk. Given the Sub-Fund invests substantially in the Master ETF as a feeder fund, it may also be subject to the risks associated with the Master ETF’s investments, including i) Equity market risk, ii) New index risk, iii) Geographical concentration risk, iv) Hong Kong listed Chinese companies risks, v) Technology sector themes concentration risks, vi) Risk associated with biotech and pharmaceutical sector, vii) Securities lending transactions risk, viii) Trading risk, ix) Tracking error risk. The value of the Sub-Fund can be volatile and may go down substantially. Investors may suffer losses.
3) The Sub-Fund may invest in derivatives for hedging or investment purposes and in adverse situations its use of financial derivative instruments may become ineffective and/or cause the Sub-Fund to suffer significant loss.
4) The Index is a new index. The Index has minimal operating history by which investors can evaluate its previous performance. There can be no assurance as to the performance of the Index. The Sub-Fund may be riskier than other exchange traded funds tracking more established indices with longer operating history.
5) As the constituents of the Index, and accordingly the Master ETF’s and the Sub-Fund’s investments, are concentrated in securities of companies having major business exposure to technology sector themes and biotech and pharmaceutical sector, and invest in companies the securities of which are listed on the SEHK and have substantial business operations in mainland China, and the Sub-Fund is subject to geographical concentration risk and sector concentration risk, its Net Asset Value is therefore likely to be more volatile than a broad-based fund.
6) You should not invest in the Sub-Fund unless the intermediary who sells it to you has explained to you that the Sub-Fund is suitable for you having regard to your financial situation, investment experience and objectives.
7) Investors should not invest in the Sub-Fund based on this document alone. Before making any investment decision, the investor should read the Sub-Fund’s offering documents carefully including the risk factors.